Severe viral infections and malignancies are known to weaken the immune system, particularly T cells, a state known as immunological "exhaustion." Overcoming immunological exhaustion is a key goal in the development of innovative drugs for cancer or severe viral infections. According to a study that was published in the journal "Immunity," Melbourne researchers have found a way to strengthen the immune response in the face of serious viral infections.
About the Author
